Ocular Therapeutix, Inc. (OCUL)
8.87
-0.63
(-6.63%)
USD |
NASDAQ |
Mar 12, 16:00
8.90
+0.03
(+0.34%)
After-Hours: 20:00
Ocular Therapeutix Total Assets (Quarterly) : 811.14M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Abbott Laboratories | 86.71B |
| EyePoint Plc | 364.00M |
| Quince Therapeutics, Inc. | 109.90M |
| Ernexa Therapeutics, Inc. | 6.172M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 156.83M |
| Shareholders Equity (Quarterly) | 654.31M |
| Debt to Equity Ratio | 0.1176 |
| Current Ratio | 15.39 |
| Net Debt Paydown Yield | -0.01% |